PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.64
Bid: 15.52
Ask: 15.64
Change: 0.26 (1.69%)
Spread: 0.12 (0.773%)
Open: 15.28
High: 15.64
Low: 15.14
Prev. Close: 15.38
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re-admission of Ordinary shares

25 Oct 2021 08:05

RNS Number : 9750P
EnQuest PLC
25 October 2021
 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

FOR IMMEDIATE RELEASE.

 

25 October 2021

 

EnQuest PLC

 

Re-admission of shares

 

EnQuest PLC ("EnQuest", or the "Company") is pleased to announce that, further to the announcement on 22 October 2021 regarding the completion of the acquisition of a 26.69% non-operated equity interest in the Golden Eagle Area Development, the Company's ordinary shares were re-admitted to the premium listing segment of the Official List and to trading on London Stock Exchange plc's main market for listed securities at 8.00 a.m. today.

 

 For more information, please contact:

EnQuest PLC Tel: +44 (0)20 7925 4900

Amjad Bseisu (Chief Executive)

Jonathan Swinney (Chief Financial Officer)

Ian Wood (Head of Investor Relations, Communications & Reporting)

Jonathan Edwards (Senior Investor Relations & Communications Manager)

 

J.P. Morgan Cazenove Tel: +44 (0)20 7742 4000

Jamie Riddell

Barry Meyers

Fraser Jamieson

 

Tulchan Communications Tel: +44 (0)20 7353 4200

Martin Robinson

Martin Pengelley

Harry Cameron

 

IMPORTANT INFORMATION

This announcement has been issued by and is the sole responsibility of the Company.

This announcement is for information purposes only and is not intended and does not constitute or form part of any offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, any securities of the Company in any jurisdiction. No public offering of securities is being made in any such jurisdiction.

The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended, or under the securities laws or with any securities regulatory authority of any state or other jurisdiction of the United States, and accordingly may not be offered, sold, pledged or transferred, directly or indirectly, in, into or within the United States. There is no intention to register any portion of any offering in the United States or to conduct a public offering of securities in the United States.

The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required by the Company and J.P. Morgan Cazenove to inform themselves about and to observe any such restrictions. Any failure to comply with this restriction may constitute a violation of the securities laws of such jurisdictions.

J.P. Morgan Securities plc (which conducts its UK investment banking activities as J.P. Morgan Cazenove) ("J.P. Morgan Cazenove") is authorised by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the FCA and the PRA. J.P. Morgan Cazenove is acting exclusively for the Company and no one else in connection with the Acquisition, Re-admission or any other matter referred to in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded its clients nor for providing advice in relation to the Acquisition, Re-admission or any other matter referred to in this announcement.

Save for the responsibilities and liabilities, if any, which may be imposed on J.P. Morgan Cazenove by FSMA or by the regulatory regime established under the Financial Services and Markets Act 2000, as amended, neither J.P. Morgan Cazenove nor any of its affiliates, directors, officers, employees, agents or advisers accepts any duty, liability or responsibility whatsoever (whether direct or indirect) to any person for, or makes any representation or warranty, express or implied, as to the contents of this announcement, including its accuracy, completeness, sufficiency or verification, or for any other statement made or purported to be made by or on its behalf in connection with the Company, the Acquisition or Re-admission and nothing in this announcement will be relied upon as a promise or representation in this respect, whether or not as to the past, present or future. J.P. Morgan Cazenove and each of its affiliates, directors, officers, employees, agents or advisers accordingly disclaim, to the fullest extent permitted by law, all and any duty, liability and responsibility whatsoever, whether direct or indirect, whether arising in tort, contract, under statute or otherwise (save as referred to above) in respect of this announcement or any such statement or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSDKBBBKBDDCKB
Date   Source Headline
5th Apr 20237:00 amRNSResults for the year ended 31 December 2022
17th Mar 20237:00 amRNS2022 Preliminary Results - revised date
15th Mar 202311:00 amRNSHolding(s) in Company
17th Feb 20237:00 amRNSTrading Statement
20th Dec 20221:35 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSChairman succession
24th Nov 20227:00 amRNSOperations Update
26th Oct 20227:00 amRNSSuccessful refinancing of capital structure
13th Oct 20227:00 amRNSPricing of new bond issue
16th Sep 20223:30 pmRNSDirector/PDMR
16th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20227:00 amRNSHalf-year Report
30th Aug 20229:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSOperations Update
1st Aug 202212:33 pmRNSDirector/PDMR Shareholding
25th Jul 202210:28 amRNSDirector/PDMR Shareholding
22nd Jul 20222:46 pmRNSDirector/PDMR Shareholding
20th Jul 20222:04 pmRNSDirector/PDMR Shareholding
18th Jul 20224:11 pmRNSDirector/PDMR Shareholding
14th Jul 20224:46 pmRNSDirector/PDMR Shareholding
20th Jun 202210:33 amRNSDirector/PDMR Shareholding
17th Jun 20223:22 pmRNSAGM Statement
17th Jun 20227:00 amRNSBoard Change
15th Jun 202212:17 pmRNSDirector/PDMR Shareholding
14th Jun 20228:44 amRNSDirector/PDMR Shareholding
1st Jun 20224:57 pmRNSHolding(s) in Company
24th May 20224:42 pmRNSNotice of AGM
23rd May 20227:00 amRNSOperations update
29th Apr 20223:00 pmRNSReport on Payments to Govts
25th Apr 20223:38 pmRNSDirector/PDMR Shareholding
25th Apr 20223:00 pmRNSHolding(s) in Company
21st Apr 20227:00 amRNSIssue of Debt
14th Apr 20223:00 pmRNSHolding(s) in Company
11th Apr 20224:45 pmRNSHolding(s) in Company
30th Mar 20227:00 amRNSProspectus publication and launch of retail notes
30th Mar 20227:00 amRNSLaunch of exchange offer
24th Mar 20227:05 amRNSAnnual Financial Report
24th Mar 20227:01 amRNSResults for the year ended 31 December 2021
24th Mar 20227:00 amRNSDirectorate Change
15th Mar 20223:00 pmRNSHolding(s) in Company
11th Mar 20223:00 pmRNSHolding(s) in Company
10th Mar 20223:00 pmRNSHolding(s) in Company
2nd Mar 20223:00 pmRNSHolding(s) in Company
28th Feb 20223:00 pmRNSHolding(s) in Company
25th Feb 20223:00 pmRNSHolding(s) in Company
24th Feb 20223:00 pmRNSHolding(s) in Company
23rd Feb 20224:16 pmRNSHolding(s) in Company
17th Feb 20221:51 pmRNSHolding(s) in Company
16th Feb 20224:57 pmRNSHolding(s) in Company
15th Feb 20223:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.